Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | melanocortin 4 receptor | Starlite/ChEMBL | References |
Homo sapiens | melanocortin 3 receptor | Starlite/ChEMBL | References |
Homo sapiens | melanocortin 5 receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | hypothetical protein | melanocortin 5 receptor | 325 aa | 311 aa | 20.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable thymidine phosphorylase DeoA (tdrpase) (pyrimidine phosphorylase) | 0.4034 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0348 | 0.0265 | 0.1652 |
Echinococcus multilocularis | thymidine phosphorylase | 0.4034 | 1 | 1 |
Onchocerca volvulus | Arrow homolog | 0.0248 | 0 | 0.5 |
Loa Loa (eye worm) | AStacin protease | 0.0535 | 0.0758 | 0.4721 |
Echinococcus granulosus | Tolloid protein 1 | 0.0856 | 0.1605 | 0.1542 |
Brugia malayi | Fibulin-1 precursor | 0.0276 | 0.0073 | 1 |
Toxoplasma gondii | calcium binding egf domain-containing protein | 0.0276 | 0.0073 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0821 | 0.1513 | 0.9427 |
Brugia malayi | Calcium binding EGF domain containing protein | 0.0276 | 0.0073 | 1 |
Loa Loa (eye worm) | bone morphogenetic protein 1b | 0.0856 | 0.1605 | 1 |
Toxoplasma gondii | calcium binding egf domain-containing protein | 0.0276 | 0.0073 | 0.5 |
Echinococcus multilocularis | Tolloid protein 1 | 0.0856 | 0.1605 | 0.1542 |
Loa Loa (eye worm) | multiple epidermal growth factor-like domains 6 | 0.0276 | 0.0073 | 0.0458 |
Mycobacterium leprae | Probable anthranilate phosphoribosyltransferase TrpD | 0.1139 | 0.2352 | 0.5 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.0545 | 0.0784 | 0.0715 |
Schistosoma mansoni | subfamily M12A unassigned peptidase (M12 family) | 0.0856 | 0.1605 | 1 |
Mycobacterium ulcerans | thymidine phosphorylase | 0.4034 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0276 | 0.0073 | 0.0458 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 300 nM | Increase in intracellular cAMP in CHO cells expressing human melanocortin receptor 5. | ChEMBL. | 11606131 |
EC50 (functional) | = 300 nM | Increase in intracellular cAMP in CHO cells expressing human melanocortin receptor 5. | ChEMBL. | 11606131 |
Ki (binding) | = 0.37 nM | Binding affinity against human melanocortin receptor 4 (hMC4R) (concentration of the peptide at 50% specific binding) | ChEMBL. | 11606131 |
Ki (binding) | = 0.37 nM | Binding affinity against human melanocortin receptor 4 (hMC4R) (concentration of the peptide at 50% specific binding) | ChEMBL. | 11606131 |
Ki (binding) | = 56 nM | Binding affinity against human melanocortin receptor 3 (hMC3R) (concentration of the peptide at 50% specific binding) | ChEMBL. | 11606131 |
Ki (binding) | = 56 nM | Binding affinity against human melanocortin receptor 3 (hMC3R) (concentration of the peptide at 50% specific binding) | ChEMBL. | 11606131 |
Ki (binding) | = 130 nM | Binding affinity against human melanocortin receptor 5 (hMC5R) (concentration of the peptide at 50% specific binding) | ChEMBL. | 11606131 |
Ki (binding) | = 130 nM | Binding affinity against human melanocortin receptor 5 (hMC5R) (concentration of the peptide at 50% specific binding) | ChEMBL. | 11606131 |
Selectivity ratio (binding) | = 150 | Ratio of binding affinity against hMC-3R to hMC4R was determined | ChEMBL. | 11606131 |
Selectivity ratio (binding) | = 350 | Ratio of binding affinity against hMC4R to hMC5R was determined | ChEMBL. | 11606131 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.